Management of cardiovascular diseases with micro systems and nanotechnology.
Cardiovascular diseases are the leading cause of death and morbidity in industrialized nations and are becoming an urgent health problem for all nations due to the unstoppable trend of an ageing and obese population. Due to the rapid development of micro total analysis systems (microTAS) and nanotechnology in recent years, they will play an important role in the diagnosis, management, and therapy of cardiovascular diseases. It is envisaged that the micro and nanotechnologies developed for treating other diseases shall be explored for cardiovascular applications to reduce the research effort required for commercializing the devices and drugs to meet the increasing demand of the cardiovascular patients.
Kong
L X
LX
Centre for Advanced Manufacturing Research, University of South Australia, Mawson Lakes, SA 5095, Australia.
Peng
Z
Z
Sugumar
D
D
D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008904:Miniaturization; D036103:Nanotechnology / Q000295:instrumentation* / Q000379:methods*; D019736:Prostheses and Implants
D002316:Cardiotonic Agents